Loading...
Genesco Inc (GCO) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is weak, with declining net income and EPS, and analysts have lowered price targets due to disappointing guidance. Additionally, insider selling has increased significantly, and technical indicators do not suggest a strong upward trend. While there is no significant positive news or trading signal, the stock may be worth monitoring for future opportunities.
The MACD histogram is negative (-0.168) and contracting, indicating bearish momentum. RSI is neutral at 46.545, showing no clear signal. Moving averages are converging, and the stock is trading near its pivot level of 27.445, with key resistance at 29.237 and support at 25.654. Overall, the technical indicators suggest a lack of strong upward momentum.

Seaport Research remains bullish on Journey's path and anticipates substantial EPS growth in FY27.
Analysts have lowered price targets due to disappointing Q3 results and revised guidance.
Insiders are selling, with a 133.76% increase in selling activity over the last month.
No recent positive news or event-driven catalysts.
Weak financial performance with a significant drop in net income (-128.29% YoY) and EPS (-128.41% YoY).
In Q3 2026, revenue increased by 3.34% YoY to $616.2M. However, net income dropped by -128.29% YoY to $5.36M, and EPS decreased by -128.41% YoY to $0.5. Gross margin also declined by 2.09% YoY to 46.84%. Overall, the financial performance indicates significant profitability challenges.
Truist, Jefferies, and Seaport Research have all lowered their price targets for GCO, citing disappointing Q3 results and revised guidance. Truist and Jefferies maintain a Hold rating, while Seaport Research retains a Buy rating, expressing long-term optimism despite near-term challenges.